Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000936392-08-000770
Filing Date
2008-12-17
Accepted
2008-12-17 16:36:28
Documents
6
Period of Report
2008-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K a50788e10vk.htm 10-K 1096138
2 EX-23.1 a50788exv23w1.htm EX-23.1 1551
3 EX-31.1 a50788exv31w1.htm EX-31.1 8200
4 EX-31.2 a50788exv31w2.htm EX-31.2 8567
5 EX-32.1 a50788exv32w1.htm EX-32.1 2792
6 EX-32.2 a50788exv32w2.htm EX-32.2 2789
  Complete submission text file 0000936392-08-000770.txt   1121561
Mailing Address 101 ENTERPRISE SUITE 300 ALISO VIEJO CA 92656
Business Address 101 ENTERPRISE SUITE 300 ALISO VIEJO CA 92656 949-389-6700
AVANIR PHARMACEUTICALS (Filer) CIK: 0000858803 (see all company filings)

EIN.: 330314804 | State of Incorp.: CA | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 001-15803 | Film No.: 081255436
SIC: 2834 Pharmaceutical Preparations